CD4؉ CD25 ؉ regulatory T cells (CD25 ؉ Tregs) play a key role in immune regulation. Since hepatitis C virus (HCV) persists with increased circulating CD4 ؉ CD25 ؉ T cells and virus-specific effector T-cell dysfunction, we asked if CD4 ؉ CD25 ؉ T cells in HCV-infected individuals are similar to natural Tregs in uninfected individuals and if they include HCV-specific Tregs using the specific Treg marker FoxP3 at the single-cell level. We report that HCV-infected patients display increased circulating FoxP3 ؉ Tregs that are phenotypically and functionally indistinguishable from FoxP3 ؉ Tregs in uninfected subjects. Furthermore, HCV-specific FoxP3 ؉ Tregs were detected in HCV-seropositive persons with antigen-specific expansion, major histocompatibility complex class II/peptide tetramer binding affinity, and preferential suppression of HCV-specific CD8 T cells. Transforming growth factor  contributed to antigen-specific Treg expansion in vitro, suggesting that it may contribute to antigen-specific Treg expansion in vivo. Interestingly, FoxP3 expression was also detected in influenza virus-specific CD4 T cells. In conclusion, functionally active and virus-specific FoxP3
؉ Tregs are induced in HCV infection, thus providing targeted immune regulation in vivo. Detection of FoxP3 expression in non-HCV-specific CD4 T cells suggests that immune regulation through antigen-specific Treg induction extends beyond HCV.Hepatitis C virus (HCV) is a highly persistent human pathogen that causes chronic necroinflammatory liver disease with progression to liver failure and cancer (25, 31). While T cells play a critical role in HCV clearance (24, 53), the virus generally persists, along with impaired antiviral effector T-cell responses (13,59,63,69). While the precise underlying mechanisms for HCV persistence and disease pathogenesis are not fully defined, a role for CD4 ϩ CD25 ϩ regulatory T cells (CD25 ϩ Tregs) has been proposed based on increased circulating CD4 ϩ CD25 ϩ T cells that can suppress HCV-specific T cells in HCV-infected patients (10,12,48,54). CD25ϩ Tregs are a subset of naturally occurring, thymus-derived CD4 ϩ regulatory T cells that highly express CD25 (the interleukin-2 [IL-2] receptor alpha chain) and play a critical role in immune tolerance to self and nonself antigens (27,44,49,51). The role of CD25 ϩ Tregs in immune regulation has been demonstrated in animal models of organ-specific autoimmune diseases, in which pathology is precipitated by their depletion and ameliorated by their reconstitution (52). The key marker of CD25 ϩ Tregs is the forkhead/winged helix family transcription factor FoxP3 (70). Impaired FoxP3 gene expression results in severe autoimmunity in human immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (8, 67) and in Scurfy mice (11); furthermore, forced FoxP3 expression in FoxP3 Ϫ T cells confers regulatory properties in vitro (21, 65). CD25 ϩ Tregs may also contribute to pathogen-specific immune regulation in viral infections, including those with hepatitis B and C, her...